VTGNVistaGen Therapeutics Inc
VTGN
VistaGen Therapeutics Inc18,111
Mkt Cap
$24.3MVolume
427,435.0052W High
$5.1452W Low
$0.43PE Ratio
-0.39VTGN Fundamentals
Price
$0.6258Prev Close
$0.6134Open
$0.614150D MA
$0.5948Beta
1.94Avg. Volume
918,120.26EPS (Annual)
-$1.67P/B
0.49Rev/Employee
$8,526.32$1.78
Vistagen Therapeutics, Inc. (NASDAQ: VTGN) Investor Alert: Schubert Jonckheer Investigating Possible False Claims Regarding Drug Candidate Following 80% Stock Drop
Vistagen Therapeutics, Inc. (NASDAQ: VTGN) Investor Alert: Schubert Jonckheer Investigating Possible False Claims Regarding Drug Candidate Following 80% Stock Drop Vistagen Therapeutics, Inc...
PR Newswire·4d ago
Vistagen Receives FDA Study May Proceed Letter Under its Refisolone IND Application, Enabling Further Phase 2 Clinical Development for the Treatment of Vasomotor Symptoms (Hot Flashes) due to Menopause
Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product candidates called pherines, today announced receipt of a Study May Proceed letter from the U.S. Food and...
Business Wire·10d ago
CLASS ACTION DEADLINE TONIGHT MONDAY, MARCH 16: Faruqi & Faruqi, LLP Reminds Vistagen Therapeutics Investors of the Securities Class Action Lawsuit Deadline Tonight
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Vistagen Therapeutics, Inc. (Vistagen or the Company) (NASDAQ: VTGN) and reminds investors of...
Business Wire·2mo ago
VTGN Deadline: VTGN Investors Have Opportunity to Lead Vistagen Therapeutics, Inc. Securities Fraud Lawsuit
VTGN Deadline: VTGN Investors Have Opportunity to Lead Vistagen Therapeutics, Inc. Securities Fraud Lawsuit VTGN Deadline: VTGN Investors Have Opportunity to Lead Vistagen Therapeutics, Inc...
PR Newswire·2mo ago
VTGN Investors Have Opportunity to Lead Vistagen Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
VTGN Investors Have Opportunity to Lead Vistagen Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm VTGN Investors Have Opportunity to Lead Vistagen Therapeutics, Inc. Securities...
PR Newswire·2mo ago
Vistagen Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - VTGN
Vistagen Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - VTGN Vistagen Therapeutics, Inc. Sued for Securities Law Violations - Contact the...
PR Newswire·2mo ago
VTGN SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Vistagen Therapeutics (VTGN) Investors of Securities Class Action Deadline on March 16, 2026
VTGN SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Vistagen Therapeutics (VTGN) Investors of Securities Class Action Deadline on March 16, 2026 VTGN SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP...
PR Newswire·2mo ago
LEVI & KORSINSKY, LLP ADVISORY TO INSTITUTIONAL INVESTORS: CLASS ACTION AGAINST VISTAGEN THERAPEUTICS MAY IMPACT PORTFOLIO HOLDINGS
LEVI & KORSINSKY, LLP ADVISORY TO INSTITUTIONAL INVESTORS: CLASS ACTION AGAINST VISTAGEN THERAPEUTICS MAY IMPACT PORTFOLIO HOLDINGS LEVI & KORSINSKY, LLP ADVISORY TO INSTITUTIONAL INVESTORS: CLASS...
PR Newswire·2mo ago
Class Action Filed Against Vistagen Therapeutics, Inc. (VTGN) - March 16, 2026 Deadline to Join - Contact Levi & Korsinsky
Class Action Filed Against Vistagen Therapeutics, Inc. (VTGN) - March 16, 2026 Deadline to Join - Contact Levi & Korsinsky Class Action Filed Against Vistagen Therapeutics, Inc. (VTGN) - March 16...
PR Newswire·2mo ago
Contact The Gross Law Firm by March 16, 2026 Deadline to Join Class Action Against Vistagen Therapeutics, Inc.(VTGN)
Contact The Gross Law Firm by March 16, 2026 Deadline to Join Class Action Against Vistagen Therapeutics, Inc.(VTGN) Contact The Gross Law Firm by March 16, 2026 Deadline to Join Class Action Against...
PR Newswire·2mo ago
<
1
2
...
>